Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “BOARD OF REGENTS”

2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,639
Index total 30,257
Page 46 / 110

Quick answer

This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,639 results for “BOARD OF REGENTS” · 30,257 patents in full index Clear search

  1. US 10118942

    Toll-like receptor 2 ligands and methods of making and using thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  2. US 10117878

    Ligands for nematode nuclear receptors and uses thereof

    The Board of Regents of the University of Texas System · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  3. US 10117907

    Glycosylated PACAP/VIP analogues with enhanced CNS penetration for treatment of neurodegenerative diseases

    Arizona Board of Regents on Behalf of the University of Arizona, a body corporate · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  4. US 10112917

    Therapeutic compounds

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  5. US 10098971

    Library of pH responsive polymers and nanoprobes thereof

    The Board of Regents of the University of Texas System · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  6. US 10098878

    HIF-2α inhibitors for treating iron overload disorders

    The Board of Regents of the University of Texas System · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  7. US 10100317

    Compositions of matter that reduce pain, shock, and inflammation by blocking linoleic acid metabolites and uses thereof

    The Board of Regents of the University of Texas System · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  8. US 10092593

    Citrate-rich calcium-magnesium supplement and uses thereof

    The Board of Regents of the University of Texas System · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  9. US 10092512

    Compositions and methods of making brittle-matrix particles through blister pack freezing

    The Board of Regents of the University of Texas System · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  10. US 10093664

    Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  11. US 10087444

    MicroRNA composition for the treatment of neuroblastoma

    The Board of Regents of the University of Texas System · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  12. US 10086091

    Method of preparation of biodegradable nanoparticles with recognition characteristics

    The Board of Regents of the University of Texas System · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  13. US 10086041

    Syndecan-4 proteoliposomes for enhanced cutaneous wound healing and minimized inflammatory immune response

    The Board of Regents of the University of Texas System · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  14. US 10086114

    Antimicrobial solutions with enhanced stability

    The Board of Regents of the University of Texas System · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  15. US 10082496

    Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis

    The Board of Regents of the University of Texas System · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  16. US 10081668

    Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  17. US 10080774

    Oncolytic adenovirus armed with therapeutic genes

    The Board of Regents of the University of Texas System · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  18. US 10080799

    Methods and compositions related to glycoprotein-immunoglobulin fusions

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  19. US 10076562

    Methods for treating plague

    The Board of Regents of the University of Texas System · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  20. US 10076538

    Compositions comprising citrate and applications thereof

    The Board of Regents of the University of Texas System · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  21. US 10076509

    Nested particles and the use thereof for coordinated delvery of active agents

    The Board of Regents of the University of Texas System · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  22. US 10073109

    Phages of biomarker capture and methods of use

    The Board of Regents of the University of Oklahoma · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  23. US 10072022

    Oridonin analogs, compositions, and methods related thereto

    The Board of Regents of the University of Texas System · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  24. US 10072062

    Methods and compositions for modification of a HLA locus

    The Board of Regents of the University of Texas System · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.